Announcements

17 September 2024
Cancers | Feature Papers from the First Half of 2024 in the Section “Clinical Research of Cancer”


As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2024 in the Section “Clinical Research of Cancer”, which are listed below:

1. “Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma”
by Sami Fares, Chase J. Wehrle, Hanna Hong, Keyue Sun, Chunbao Jiao, Mingyi Zhang, Abby Gross, Erlind Allkushi, Melis Uysal, Suneel Kamath et al.
Cancers 2024, 16(8), 1453; https://doi.org/10.3390/cancers16081453
Available online: https://www.mdpi.com/2072-6694/16/8/1453

2. “Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts”
by Jacqueline Schönherr, Philipp Seifert, Falk Gühne, Thomas Winkens, Falk Rauchfuß, Utz Settmacher, Martin Freesmeyer and Robert Drescher
Cancers 2024, 16(1), 235; https://doi.org/10.3390/cancers16010235
Available online: https://www.mdpi.com/2072-6694/16/1/235

3. “Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group”
by Vanessa L. Mettmann, Claudia Blattmann, Godehard Friedel, Semi Harrabi, Thekla von Kalle, Leo Kager, Matthias Kevric, Thomas Kühne, Michaela Nathrath, Benjamin Sorg et al.
Cancers 2024, 16(2), 275; https://doi.org/10.3390/cancers16020275
Available online: https://www.mdpi.com/2072-6694/16/2/275

4. “Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment”
by Zuzanna Pelc, Katarzyna Sędłak, Radosław Mlak, Magdalena Leśniewska, Katarzyna Mielniczek, Piotr Rola, Jacek Januszewski, Olena Zhaldak, Anna Rekowska, Katarzyna Gęca et al.
Cancers 2024, 16(4), 828; https://doi.org/10.3390/cancers16040828
Available online: https://www.mdpi.com/2072-6694/16/4/828

5. “Emerging Therapies for Glioblastoma”
by Stella Aimé Rios, Stephanie Oyervides, David Uribe, Angelica Maree Reyes, Victor Fanniel, Jonathan Vazquez and Megan Keniry
Cancers 2024, 16(8), 1485; https://doi.org/10.3390/cancers16081485
Available online: https://www.mdpi.com/2072-6694/16/8/1485

6. “Chondrosarcoma of the Femur: Is Local Recurrence Influenced by the Presence of an Extraosseous Component?”
by Minna K. Laitinen, Michael C. Parry, Guy V. Morris, Robert J. Grimer, Vaiyapuri Sumathi, Jonathan D. Stevenson and Lee M. Jeys
Cancers 2024, 16(2), 363; https://doi.org/10.3390/cancers16020363
Available online: https://www.mdpi.com/2072-6694/16/2/363

7. “Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management”
by Ying Cong, Nick Devoogdt, Philippe Lambin, Ludwig J. Dubois and Ala Yaromina
Cancers 2024, 16(2), 371; https://doi.org/10.3390/cancers16020371
Available online: https://www.mdpi.com/2072-6694/16/2/371

8. “Surgical De-Escalation for Re-Excision in Patients with a Margin Less Than 2 mm and a Diagnosis of DCIS”
by Gianluca Vanni, Marco Pellicciaro, Nicola Di Lorenzo, Rosaria Barbarino, Marco Materazzo, Federico Tacconi, Andrea Squeri, Rolando Maria D’Angelillo, Massimiliano Berrettaa and Oreste Claudio Buonomo
Cancers 2024, 16(4), 743; https://doi.org/10.3390/cancers16040743
Available online: https://www.mdpi.com/2072-6694/16/4/743

9. “The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research”
by Nina Yu and Orwa Aboud
Cancers 2024, 16(6), 1089; https://doi.org/10.3390/cancers16061089
Available online: https://www.mdpi.com/2072-6694/16/6/1089

10. “Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

More News...
Back to TopTop